Therapure seeks $130 mln in this year's first Canadian PE-backed IPO
Therapure Biopharma, a Canadian biopharmaceutical company owned by Catalyst Capital Group, has set the terms of its previously announced initial public offering. Therapure is seeking about $130 million, according to an IPO prospectus amended earlier this month. The offering includes a secondary sale by Catalyst.
20 January 2016•2 mins read
